Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: An in vitro pharmacodynamic simulation

Journal of Chemotherapy

Volumn 12, Issue 2, 2000, Pages 124-128

  Fenoll, A ^a   Casal, J ^a   Gimenez M J ^b   Jado, I ^a   Aguilar Alfaro, Lorenzo ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amoxicillin; Bactericidal activity; Cefotaxime; Streptococcus pneumoniae; lactams

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034106813     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.2.124     Document Type: Article

References (9)

1. 1 García de Lomas J, Torrellas A, García Rodríguez JA, Baquero F. A national, multicenter, and prospective survey of respiratory bacteria susceptibility to 12 commonly used antimicrobials in Spain. In: Program and Abstracts of the Thirty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, American Society for Microbiology. Washington, DC. 1997: Abstract E-102, p. 132.
2. 2 Garau J, Aguilar L, Rodríguez-Creixems M, et al. Influence of comorbidity and severity on the clinical outcome of bacteremic pneumococcal pneumonia treated with β-lactam monotherapy. J Chemother 1999; 11: 266-272.
3. 3 Pallarés R, Liñares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
4. 4 Balcabao IP, Aguilar L, Martin M, García Y, Dal-Ré R, Prieto J. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation. Antimicrob Agents Chemother 1996; 40: 2904-2906.
5. 5 Soriano F, Ponte C, Nieto E, Parra A. Correlation of "in vitro" activity and pharmacokinetic parameters with "in vivo" effect of amoxicillin, co-amoxiclav and cefotaxime in an experimental pneumonia with Streptococcus pneumoniae in mice. J Antimicrob Chemother 1996; 38: 227-236.
6. 6 Aguilar L, Rosendo J, Balcabao IP, et al. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study. Antimicrob Agents Chemother 1997; 41: 1389-1391.
7. 7 National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - Third Edition: Approved Standard M7-A3. NCCLS Villanova, Pa., 1993.
8. 8 Prieto J, Giménez MJ, Balcabao IP, Gómez-Lus ML, Aguilar L. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation. J Chemother 1999; 11 (5): 345-348.
9. 9 Amsterdam D. Assessing cidal activity of antimicrobial agents: problems and pitfalls. The Antimicrob Newslett 1990; 7: 49-56.